Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod in Naive vs Previously Treated RRMS Patients
NCT01498887Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of fingolimod in relapsing-remitting multiple sclerosis (RRMS), sponsored by Novartis. Started Dec 2011; status: completed.
02
Drugs
fingolimod
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01498887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01498887.